Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UQCRHP3 is a pseudogene, meaning it is a non-functional copy of a gene derived from the ubiquinol-cytochrome c reductase hinge protein (UQCRH), a component of mitochondrial complex III involved in electron transfer in the respiratory chain. However, as a pseudogene, UQCRHP3 is not translated into a functional protein and does not participate in mitochondrial respiratory activity, biological signaling pathways, or serve as a direct drug target. There are no documented therapeutic, disease, or biomarker roles for UQCRHP3, and it does not interact with drugs or represent a safety concern. Pseudogenes are sometimes used in genomic studies for evolutionary or regulation analysis, but UQCRHP3 itself is not considered a therapeutic target nor a receptor, enzyme, transporter, or transcription factor. The presence of “pseudogene” in the name indicates this is not a protein-coding gene and does not yield a functional protein product, thereby disqualifying it as a standard drug target or molecular marker. UQCRH, its parent protein, is a hinge protein of Complex III (cytochrome bc1 complex) and participates in the electron transport chain, but UQCRHP3 lacks that functional capability. Literal nomenclature and capitalization conventions have been applied per instructions. There is nothing therapeutically actionable or receptor-related about UQCRHP3, and its status as a pseudogene means information such as molecular classification, biological function, disease relevance, or drug interactions is not applicable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquinol-cytochrome c reductase hinge protein pseudogene 3 (UQCRHP3).